Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China flag China · Delayed Price · Currency is CNY
19.34
+0.54 (2.87%)
Nov 2, 2026, 3:04 PM CST

SHE:002773 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
914.121,1631,1911,045896.67421.08
Depreciation & Amortization
238.14238.14230.41222.6158.27149.38
Other Amortization
5.795.793.983.724.572.44
Loss (Gain) From Sale of Assets
-0.01-0.01-0.01-0.01--
Asset Writedown & Restructuring Costs
6.196.191.141.350.68215.06
Loss (Gain) From Sale of Investments
-36.24-36.24-47.28-45.03-38.06-26.43
Stock-Based Compensation
-0.55-0.551.06---
Provision & Write-off of Bad Debts
0.360.360.390.24-0.4-2.64
Other Operating Activities
-362.58-15.02-12.16-11.9-27.740.97
Change in Accounts Receivable
-3.01-3.01-45.75-5.8216.12151.98
Change in Inventory
-22.16-22.1613.79-65.01-38.46-57.03
Change in Accounts Payable
37.9937.99-30.38-61.36-116.71-249.47
Change in Other Net Operating Assets
2.052.051.753.827.794.71
Operating Cash Flow
907.251,5041,4121,218925.15494.11
Operating Cash Flow Growth
-42.05%6.50%15.88%31.70%87.23%80.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-308.66-262.48-159.39-138.87-355.21-569.42
Sale of Property, Plant & Equipment
0.220.210.550.20.060.08
Investment in Securities
-404--100100-251.85
Other Investing Activities
2936.946.7945.2939.618.06
Investing Cash Flow
-683.44-225.37-112.066.62-215.55-803.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Repaid
--1.92-1.49-1.99-2.6-2.13
Lease Payments
-1.92-1.92-1.49-1.99-2.6-2.13
Total Debt Repaid
-1.92-1.92-1.49-1.99-2.6-2.13
Net Debt Issued (Repaid)
-1.92-1.92-1.49-1.99-2.6-2.13
Issuance of Common Stock
0.0733.246.75---
Common Dividends Paid
-644.93-552.67-349.4-137.92-91.95-91.95
Other Financing Activities
-0.281.83-9.4120.715.24
Financing Cash Flow
-647.05-519.52-344.14-130.5-73.85-78.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.01-0.48-0.25-0.210.99-0.87
Net Cash Flow
-423.26758.28955.431,094636.74-388.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
598.591,2411,2521,080569.95-75.3
Free Cash Flow Growth
-55.48%-0.90%16.02%89.41%--
Free Cash Flow Margin
14.48%27.07%28.13%27.28%16.82%-2.09%
Free Cash Flow Per Share
0.651.341.371.180.62-0.08
Levered Free Cash Flow
283.61668.82851.56681.33398.96-399.12
Unlevered Free Cash Flow
283.61668.82851.56681.33398.96-399.12
Free Cash Flow After Leases
596.671,2391,2511,078567.35-77.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
602.81434.85400.54391.52343.76450.78
Change in Working Capital
142.03142.0343.122.66-68.84-265.76